Location of Repository

The Pathogenesis of Uterine Adenomyosis

By Mohamed Khairy Mehasseb

Abstract

The exact aetiology and pathogenesis of uterine adenomyosis are not clear. Increased endometrial invasiveness has been proposed in the literature, but without conclusive evidence. This thesis was undertaken to examine the pathogenesis of adenomyosis and the differences between affected and unaffected uteri, testing two possibilities with adenomyosis: (i) that the myometrium is permissive to invasion by a normal basal endometrium, or (ii) that the basal endometrium has a higher invasive potential and penetrates a normal myometrium.\ud To examine the early phases of development of adenomyosis, a mouse model was used, where adenomyosis was induced by dosing female pups with tamoxifen. The same experiment was used on C57/BL6J strain to examine strain differences in response to tamoxifen and predisposition to adenomyosis. Adenomyosis in the human uterus was characterised, examining the immunohistochemical, light and electron microscopy structure, and RNA microarrays of affected and unaffected uteri. The invasive properties of the stroma and its interaction with the underlying myometrium were further studied in a co-culture model.\ud Adenomyosis was successfully induced in the CD1 mice, with abnormal development and disruption of the inner circular myometrium. However, the C57/BL6J did not develop adenomyosis inspite of the presence of inner myometrial abnormalities comparable to the CD1 mice. Affected human uteri showed distinct myometrial features such as reduced myometrial cellular density and enlarged nuclei with hypertrophy and hyperplasia seen on light microscopy. Electron microscopy revealed ultrastructural features (e.g. reduced caveolae and increased myelin bodies, intermediate filaments and dense bands) in adenomyotic uteri. A large number of dysregulated genes were detected between affected and unaffected uteri, with Wnt5a being a key downregulated gene.\ud Steroid reception expression was equally altered in cases of adenomyosis (e.g. reduced progesterone receptors and increased estrogen receptor beta). Increased vimentin immunostaining was equally observed in the inner myometrium of diseased uteri. An increased adenomyotic stromal invasiveness and increased myometrial permissiveness was observed in the co-culture model.\ud The thesis demonstrates that the endometrial – myometrial interface behaves differently in uteri with adenomyosis, concluding that adenomyosis is a uterine disease characterized by both increased endometrial invasiveness and myometrial defects that play a facilitative role for this invasion. Both the myometrium and endometrial stroma of diseased uteri show a unique phenotype, gene expression and protein expression profiles

Publisher: University of Leicester
Year: 2011
OAI identifier: oai:lra.le.ac.uk:2381/9048

Suggested articles

Preview

Citations

  1. (2001). [Eutopic and ectopic endometrium in endometriosis].
  2. (1999). 3D-angio of adenomyotic uteri. In:
  3. (1989). A concordance correlation coefficient to evaluate reproducibility.
  4. (2002). A matrix metalloproteinase inhibitor, ONO-4817, retards the development of mammary tumor and the progression of uterine adenomyosis in mice.
  5. (1995). A murine model of adenomyosis: the effects of hyperprolactinemia induced by fluoxetine hydrochloride, a selective serotonin reuptake inhibitor, on adenomyosis induction in Wistar albino rats.
  6. (2000). A note on the concordance correlation coefficient.
  7. (1967). A study of newt mitotic chromosomes by negative staining.
  8. (2000). Aberrant expression of glutathione peroxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis.
  9. (2007). Abnormal mesenchymal markers expression in adenomyosis uteri,
  10. (1953). Accuracy of endometrial dating; correlation of endometrial dating with basal body temperature and menses.
  11. (1987). Adenomyosis and leiomyoma: differential diagnosis with MR imaging.
  12. (2007). Adenomyosis and risk of preterm delivery.
  13. (1995). Adenomyosis at hysterectomy: a study on frequency distribution and patient characteristics.
  14. (1997). Adenomyosis at hysterectomy: prevalence and relationship to operative findings and reproductive and menstrual factors.
  15. (2001). Adenomyosis demonstrates increased expression of the basic fibroblast growth factor receptor/ligand system compared with autologous endometrium.
  16. (2005). Adenomyosis in endometriosis--prevalence and impact on fertility.
  17. (1980). Adenomyosis in mice.
  18. (1990). Adenomyosis in Pakistani women: four year experience at the
  19. (1995). Adenomyosis in postmenopausal breast cancer patients treated with tamoxifen: a new entity?
  20. (2004). Adenomyosis in the baboon is associated with primary infertility.
  21. (1988). Adenomyosis uteri: a study of 416 cases.
  22. (2009). Adenomyosis uteri: an update.
  23. (1925). Adenomyosis uteri.
  24. (1987). Adenomyosis uteri. A prospective study in Trinidad & Tobago (January-May,
  25. (1982). Adenomyosis uteri. Report on a 15-year study (1966-1980) at the University Hospital of the West Indies.
  26. (1995). Adenomyosis with sparse glands. A potential mimic of low-grade endometrial stromal sarcoma.
  27. (2001). Adenomyosis--a result of disordered stromal differentiation.
  28. (1971). Adenomyosis: a clinical and pathological appraisal.
  29. (1977). Adenomyosis: a neglected diagnosis.
  30. (1958). Adenomyosis: a reappraisal of symptomatology.
  31. (1989). Adenomyosis: a retrospective view.
  32. (1989). Adenomyosis: current perspectives.
  33. (1994). Adenomyosis: prospective comparison of MR imaging and transvaginal sonography.
  34. (2000). Adenomyosis: sonographic findings and diagnostic accuracy.
  35. (1981). Adenomyosis: study in a Jewish female population.
  36. (2000). Adenomyosis: symptoms, histology, and pregnancy terminations.
  37. (2000). Adenomyosis: US features with histologic correlation in an in-vitro study.
  38. (1965). Alterations in the cytologic detail of intestinal smooth muscle cells in various stages of contraction.
  39. (1956). An electron microscopy study of uterine smooth muscle.
  40. (2002). Analysis of genetic aberrations in uterine adenomyosis using comparative genomic hybridization.
  41. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T
  42. (2001). Androgen, estrogen and progesterone receptor expression in the human uterus during the menstrual cycle.
  43. (1991). Animal model of uterine adenomyosis: is prolactin a potent inducer of adenomyosis in mice?
  44. (1999). Apoptosis in the endometrium.
  45. (1931). Beitrag zur Frage der Adenomyosis.
  46. (1981). Biochemical analyses of separated epithelium and stroma from endometria of premenopausal and postmenopausal women receiving estrogen and progestins.
  47. (1993). Calcium pump of the plasma membrane is localized in caveolae.
  48. (2008). Cellular density in myometrium and junctional zone in tamoxifen-induced and spontaneous adenomyosis, 10th World Congress of Endometriosis,
  49. (1991). Characterisation of subendometrial myometrial contractions throughout the menstrual cycle in normal fertile women.
  50. (1984). Characterization and regulation in the expression of a gene encoding for the intermediate filament protein desmin.
  51. (1995). Chromosome analysis of uterine adenomyosis. Detection of the leiomyoma-associated del(7q) in three cases.
  52. (1980). Clinical significance of adenomyosis.
  53. (2009). Coculture of decidua and trophoblast to study proliferation and invasion.
  54. (1994). Comparative immunohistochemical study of oestrogen and progesterone receptors in the Fallopian tube and uterus at different stages of teh menstrual cycle and the menopause.
  55. (2007). Comparison of 2-, 3D and doppler ultrasound with histological findings in adenomyosis.
  56. (1988). Comparison of magnetic resonance imaging and ultrasound in evaluating follicular and endometrial development throughout the normal cycle.
  57. (2003). Comparison of the effect of oestradiol, tamoxifen and raloxifene on nerve growth factoralpha expression in specific neonatal mouse uterine cell types using laser capture microdissection.
  58. (2001). Comparisons of the effects of tamoxifen, toremifene and raloxifene on enzyme induction and gene expression in the ovariectomised rat uterus.
  59. (1993). Complementary distributions of vinculin and dystrophin define two distinct sarcolemma domains in smooth muscle.
  60. (1984). Confirmation of the preoperative diagnoses for hysterectomy.
  61. (2009). Constitutive activation of Betacatenin in uterine stroma and smooth muscle leads to the development of mesenchymal tumors in mice.
  62. (2001). Contraction of fibroblast-containing collagen gels: initial collagen concentration regulates the degree of contraction and cell survival.
  63. (1990). Contractions of the inner third of the myometrium.
  64. (2002). Correlations between extent and spread of adenomyosis and clinical symptoms.
  65. (1990). Critical period of induction by tamoxifen of genital organ abnormalities in female mice.
  66. (1994). Cyclic bcl-2 gene expression in human uterine endometrium during menstrual cycle.
  67. (2007). Cyclical changes in the cellular density of the junctional zone myometrium in normal and adenomyotic uteri,
  68. (1983). Cytokeratins of normal epithelial and some neoplasms of the female genital tract.
  69. (1992). Cytoskeletal filaments in the smooth muscle cells of uterine leiomyomata and myometrium: an ultrastructural and immunohistochemical analysis. Virchows Arch A Pathol Anat Histol,
  70. (1965). Der Uterusmuskel: Morphologie.
  71. (1984). Development of smooth muscle iin the human fetal uterus: an ultrastructural study.
  72. Developmental pattern of estrogen receptor expression in female mouse genital tracts.
  73. (1979). Diagnostic electron microscopy in gynecologic pathology.
  74. Die adenomyomata und cystadenomata der uterus und tubenwandug: ihre abkunft von resten des Wolff’schen koerpers. August Hirschwald Verlag,
  75. (2008). Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium.
  76. (2008). Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids.
  77. (1998). Differential expression patterns of Wnt genes in the murine female reproductive tract during development and the estrous cycle.
  78. (1980). Differential response of individual uterine cell types from immature rats treated with estradiol.
  79. (2008). Differing responses of human follicular and nonfollicular scalp cells in an in vitro wound healing assay: effects of estrogen on vascular endothelial growth factor secretion. Wound Repair and Regeneration,
  80. (1996). Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation.
  81. (1995). Diffuse uterine adenomyosis: morphologic criteria and diagnostic accuracy of endovaginal sonography.
  82. (2006). Disordered myometrial organisation during early uterine development in tamoxifen-induced adenomyosis,
  83. (1996). Disruption of muscle architecture and myocardial degeneration in mice lacking desmin.
  84. (2002). Disruption of the endometrial-myometrial border during pregnancy as a risk factor for adenomyosis.
  85. (2003). Distinctive proliferative phase differences in gene expression in human myometrium and leiomyomata.
  86. (2001). Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis.
  87. (2000). Does cesarean delivery increase the prevalence of adenomyosis? A retrospective review.
  88. (1992). Effects of danazol at the immunologic level in patients with adenomyosis, with special reference to autoantibodies: a multi-center cooperative study.
  89. (1982). Effects of prenatal exposure of mice to "lowdose" diethylstilbestrol and the development of adenomyosis associated with evidence of hyperprolactinemia.
  90. (2002). Elastin distribution in the myometrial and vascular smooth muscle of the human uterus.
  91. (1960). Electron microscopic studies on the smooth muscle of the human uterus.
  92. (2009). EMT: when epithelial cells decide to become mesenchymal-like cells.
  93. (2000). Endocrine disruption and developmental abnormalities of female reproduction.
  94. (1995). Endometrial ablation for postmenopausal uterine bleeding induced by hormone replacement therapy.
  95. Endometrial histomorphometry of trimegestone-based sequential hormone replacement therapy: a weighted comparison with the endometrium of the natural cycle.
  96. (2002). Endometrial hyperplasia, polyps, and adenomyosis associated with unopposed estrogen in rhesus monkeys (Macaca mulatta).
  97. (2008). Endometrial stroma and myometrial interaction in uterine adenomyosis: a novel three-dimensional co-culture model, Blair-Bell Research Society meeting,
  98. (2001). Endometrial stromal cells regulate epithelial cell growth in vitro: a new coculture model.
  99. (1989). Endometrial tissue in myometrial vessels not associated with menstruation.
  100. (2000). Endometrialmyometrial interface: relationship to adenomyosis and changes in pregnancy.
  101. (1999). Endometriosis and free radicals.
  102. (1934). Endometriosis as a manifestation of ovarian dysfunction.
  103. (1996). Endometriosis associated with the N314D mutation of galactose-1-phosphate uridyl transferase (GALT).
  104. (1970). Endometriosis in rhesus monkeys.
  105. (2002). Endometriosis results from the dislocation of basal endometrium.
  106. (1998). Endometriosis: a dysfunction and disease of the archimetra. Hum Reprod Update,
  107. (1995). Endovaginal ultrasonography in the diagnosis of adenomyosis uteri: identifying the predictive characteristics.
  108. (2010). Enhanced invasion of stromal cells from adenomyosis in a three-dimensional coculture model is augmented by the presence of myocytes from affected uteri. Fertil Steril (In Press). Accepted for publication 08
  109. (2003). Epithelial-mesenchymal transition and its implications for fibrosis.
  110. (2002). Epithelial-mesenchymal transitions in tumour progression.
  111. (2001). Epithelial-stromal tissue interaction in paramesonephric (Mullerian) epithelial differentiation.
  112. (1986). Estrogen and progestin receptors in human uterus: reference ranges of clinical conditions.
  113. (1992). Estrogen receptor expressin in genital tract of female mice treated neonatally with diethylstilbestrol.
  114. (2006). Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast.
  115. (2006). Estrogen receptor-β is expressed in stromal cells of fibroadenoma and phylloides tumors of the breast.
  116. (1980). Estrogen receptors in the fetal mouse.
  117. (1984). Estrogen replacement therapy and benign breast disease.
  118. (1993). Evidence for estrogen synthesis in adenomyotic tissues.
  119. Evidence from magnetic resonance imaging.
  120. (1985). Evidence tat tamoxifen is a histamine antagonist.
  121. (2006). Experimental adenomyosis.
  122. (2004). Expression of apoptosis-related proteins in adenomyotic uteri treated with danazol and GnRH agonists.
  123. (2000). Expression of estrogen receptor beta is developmentally regulated in reproductive tissues of male and female mice.
  124. (1996). Expression of gamma delta T cells and adhesion molecules in endometriotic tissue in patients with endometriosis and adenomyosis.
  125. (2009). Expression of insulin-like growth factors (IGFs) and IGF signaling: molecular complexity in uterine leiomyomas.
  126. (1993). Expression of major histocompatibility complex class II antigen in endometriotic tissue in patients with endometriosis and adenomyosis.
  127. (2008). Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation.
  128. (2007). Expression profile of several genes in human myometrium and uterine leiomyoma.
  129. (1978). Female reproductive system.
  130. (2006). From genomics to chemical genomics: new developments in KEGG.
  131. (2004). Functional characterization of somatic point mutations of the human estrogen receptor alpha (hERalpha) in adenomyosis uteri.
  132. (2007). Functional genomics of the pregnant uterus: from expectations to reality, a compilation of studies in the myometrium.
  133. (1998). G protein signalling pathways in myometrium: affecting the balance between contraction and relaxation.
  134. (2006). Gene and protein expression in the myometrium in pregnancy and labor.
  135. (2005). Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta.
  136. (2009). Gene expression profiling of multiple leiomyomata uteri and matched normal tissue from a single patient.
  137. (2004). Gene expression profiling of neonatal mouse uterine development.
  138. (1997). Glutathione S-transferase M1 gene polymorphism and susceptibility to endometriosis in a French population.
  139. (1997). High frequency of adenomyosis in postmenopausal breast cancer patients treated with tamoxifen.
  140. (1989). Histologic, morphometric, and immunocytochemical analysis of myometrial development in rats and mice: II.
  141. (1994). Histological analysis of spontaneous adenomyosis-like changes in recombinant inbred mouse uterus (SMXA mouse)--a novel animal model for adenomyosis].
  142. (2010). Histomorphometric analysis of gonadal steroid receptors distribution in uteri with and without adenomyosis through the menstrual cycle,
  143. (1999). Human decidual stromal cells express α-smooth muscle actin and show ultrastructural similarities with myofibroblasts.
  144. (2005). Human myometrial gene expression before and during parturition.
  145. (1973). Hypertrophy and hyperplasia in the mouse uterus after oestrogen treatment: an autoradiographic study.
  146. (1992). Hysteroscopic myometrial biopsy: its use in diagnosing adenomyosis and its clinical application.
  147. (2003). Identification, Characterization, and Regulation of the Canonical Wnt Signaling Pathway in Human Endometrium.
  148. (1998). IFN-gamma is produced by polymorphonuclear neutrophils in human uterine en- dometrium and by cultured peripheral blood polymorphonuclear neutrophils.
  149. (1998). Imaging features of adenomyosis.
  150. (1992). Immunocytochemical analysis of oestrogen receptors and progesterone receptors in the human uterus throughout the menstrual cycle and after teh menopause.
  151. (2004). Immunohistochemical analysis of estrogen receptor alpha, estrogen receptro beta and progesterone receptor in normal human endometrium.
  152. (1988). Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle.
  153. (1999). Immunohistochemical assessment of superoxide dismutase expression in the endometrium in endometriosis and adenomyosis.
  154. Immunohistochemical localization of heat shock proteins hsp70 and hsp90 in the human endometrium: correlation with sex steroid receptors and ki-67 antigen expression.
  155. (1988). Immunohistochemical study of distribution of estrogen receptors in corpus and cervix uteri.
  156. (2000). Immunolocalisation of oestrogen receptor beta in human tissues.
  157. (2001). Impact of ultrasound diagnosis of adenomyosis on recipients of sibling oocytes.
  158. (1991). Incidence of adenomyosis uteri in a Greek population.
  159. (1992). Increase of DNA synthesis in uterine adenomyosis in mice with ectopic pituitary isograft.
  160. (1993). Increased expression of human chorionic gonadotropin/human luteinizing hormone receptors in adenomyosis.
  161. (1993). Induction of a polarized micro-environment by human T cells and interferon-gamma in three-dimensional speroids cultures of human endometrial epithelial cells.
  162. (1991). Induction of HLA-DR expression in endometrial epithelial cells by endometrial T-cells: potential regulatory role of endometrial T-cells in vivo.
  163. (1986). Inhibition of protein kinase C mediated signal transduction by tamoxifen.
  164. (1994). Insights from the study of animals lacking functional estrogen receptor.
  165. (1997). Integrin adhesion molecules in the endometrial glandular epithelium in patients with endometriosis or adenomyosis.
  166. (1990). Interaction of antiestrogens with binding sites for muscarinic cholinergic drugs and clacium channel blockers in cell membranes.
  167. (1980). Intermediate filaments as mechanical integrators of cellular space.
  168. (1998). Intraepithelial leukocytes in endometriosis and adenomyosis: comparison of eutopic and ectopic endometrium with normal endometrium.
  169. (1995). Invasiveness of endometriotic cells in vitro.
  170. (1998). Is adenomyosis an immune disease? Hum Reprod Update,
  171. (2004). Is prior uterine surgery a risk factor for adenomyosis?
  172. (1991). Junctional zone of the uterus: correlation of MR imaging and histologic examination of hysterectomy specimens.
  173. (2009). KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res.
  174. (2000). KEGG: kyoto encyclopedia of genes and genomes.
  175. (1998). Laminin β2 distinguishes inner and outer layers of the human myometrium.
  176. (2004). Laminin: the crux of basement membranes assembly.
  177. (2005). Leiomyoma and myometrial gene expression profiles and their responses to gonadotropinreleasing hormone analog therapy.
  178. (1985). Long-term responses of the mouse uterus to neonatal diethylstilbestrol treatment and to later sex hormone exposure.
  179. (2000). Loss of heterozygosity in adenomyosis on hMSH2, hMLH1, p16Ink4 and GALT loci.
  180. (1983). Mechanisms of development of prolactin-induced adenomyosis in mice.
  181. (2008). Microarray study of gene expression in uterine leiomyoma.
  182. (1996). Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci.
  183. (1997). Modulation of myoepithelial-associated alpha6beta4 integrin in a breast cancer cell line alters invasive potential.
  184. (2006). Molecular characterization of human adenomyosis.
  185. (2005). Monocyte chemotactic protein-1 expression is increased in human gestational tissues during term and preterm labor.
  186. (1983). Morphometric measurement of cellular hypertrophy.
  187. (2007). MR imaging of the uterus and cervix in healthy women: determination of normal values.
  188. (1998). Myometrial zonal differentiation and uterine junctional zone hyperplasia in the non-pregnant uterus. Hum Reprod Update,
  189. (2010). Neonatal administration of tamoxifen causes disruption of myometrial development but not adenomyosis in the C57/BL6J mouse. Reproduction
  190. (2005). Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancer.
  191. (1980). Non-neoplastic conditions of the myometrium and uterine serosa. Surgical pathology of the uterine corpus.
  192. (1984). Non-specificity of symptoms related to adenomyosis. A prospective comparative survey.
  193. (1961). Norethynodrel-treated endometriosis: a morphological and histochemical study.
  194. (1982). Normal development of the human female reproductive tract and alterations resulting from experimental exposure to diethylstilbesterol.
  195. (2003). Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin.
  196. (2010). Oral Presentations arising from the thesis 1. Enhanced invasion of stromal cells from adenomyosis in a threedimensional co-culture model is augmented by the presence of myocytes from affected uteri,
  197. (1992). Ovarian steroid receptor expression in endometriosis and in two potential parent epithelia: endometrium and peritoneal mesothelium.
  198. (1989). Participation of Tenascin and TGF-beta in reciprocal epithelial-mesenchymal interactions of MCF7 cells and fibroblasts.
  199. (2008). Pathogenesis of uterine adenomyosis, Reproductive Sciences Section seminar,
  200. (1997). Pathogenetic role of the stromal cells in endometriosis and adenomyosis.
  201. (1986). Pathological changes induced in the uterus of mice with the prolonged administration of progesterone and 19-nor-contraceptives.
  202. (1994). Pathology in gynecology and obstetrics.
  203. (1998). Pathophysiology of adenomyosis.
  204. (1993). Pelvic MR imaging findings in gestational trophoblastic disease, incomplete abortion, and ectopic pregnancy: are they specific?
  205. (1997). Physiological action of progesterone in target tissues.
  206. (2002). Plasticity, niches, and the use of stem cells.
  207. (1997). Potent inhibition by tamoxifen of spontaneous and agonist-induced contractions of the human myometrium and intramyometrial arteries.
  208. (2009). Presentations arising from the thesis 1. Uterine adenomyosis is associated with ultrastructural features of altered contractility in the inner myometrium, Society for Gynaecologic Investigation (SGI) meeting,
  209. (2008). Presenting and exploring biological pathways with PathVisio.
  210. (2001). Prevalence and risk factors of adenomyosis at hysterectomy.
  211. (2003). Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down regulation of MMP expression in fibroblasts and tumour cells.
  212. (1985). Prior cesarean section. A risk factor for adenomyosis?
  213. (1997). Product differentiation by analysis of DNA melting curves during the polymerase chain reaction.
  214. (2005). Protein identification and analysis tools on the ExPASy server. In:
  215. Protein identification with sequence tags.
  216. (2010). Publications arising from the thesis 1. Mehasseb
  217. (2006). Purified Wnt5a protein activates or inhibits betacatenin-TCF signaling depending on receptor context.
  218. (2007). Quick calculation for sample size while controlling false discovery rate with application to microarray analysis.
  219. (2002). Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
  220. (1997). Regulation of progeserone receptor messenger ribonucleic acid by progestin in human endometrial stromal cells.
  221. (1993). Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists.
  222. (1995). Regulation of sex steroid receptor gene expression by progesterone and testosterone in cultured human endometrial stromal cells.
  223. (1997). Relation between endometrial wavelike activity and fecundability in spontaneous cycles.
  224. (1994). Relationship between cellular DNA synthesis, PCNA expression and sex steroid hormone receptor status in the developing mouse ovary, uterus and oviduct.
  225. (1996). Relationship between the expression of cyclins/cyclin-dependent kinases and sex-steroid receptors/ Ki67 in normal human endometrial glands and stroma during the menstrual cycle.
  226. (1961). Relationship of adenomyosis uteri to endometrial hyperplasia and endometrial carcinoma.
  227. (1998). Reproducibility in the quantification of mRNA levels by RT-PCR-ELISA and RT competitive-PCR-ELISA.
  228. (2002). Reproducibility of evaluation of the uterus by transvaginal sonography, hysterosonographic examination, hysteroscopy and magnetic resonance imaging.
  229. (2007). Retinoic acid pathway genes show significantly altered expression in uterine fibroids when compared with normal myometrium.
  230. (1997). Risk factors for adenomyosis.
  231. (1989). Robbins pathological basis of disease .
  232. (1992). Role of epithelial-mesenchymal interactions in the differentiation and spatial organization of visceral smooth muscle.
  233. (1989). Role of uterine epithelium in the development of myometrial smooth muscle cells.
  234. (1994). Sequential appearance of musclespecific proteins in myoblasts as a function of time after cell division: evidence for a conserved myoblast differentiation program in skeletal muscle.
  235. (2005). Sex steroids modulate human aortic smooth muscle cell matrix protein deposition and matrix metalloproteinase expression.
  236. Signal transducer and activator of transcription-1 and heat shock factor-1 interact and activate the transcription of the Hsp-70 and Hsp-90b gene promoters.
  237. (1981). Smooth muscle cell hypertrophy versus hyperplasia in hypertension.
  238. (1989). Smooth muscle differentiation at endometrio-myometrial junction. An ultrastructural study. Virchows Arch A Pathol Anat Histol,
  239. (1998). Sperm transport in the human female genital tract and its modulation by oxytocin as assessed by hysterosalpingography, hysterotonography, electronhysterography and Doppler sonography. Hum Reprod Update,
  240. (2000). Sporadic cardiac and skeletal myopathy caused by a de nove desmin mutation.
  241. (1979). Steroid receptor levels and histology of endometriosis and adenomyosis.
  242. (1990). Strain differences in the ontogeny of estrogen receptors in murine uterine epithelium.
  243. (1982). Strain-difference in the induction of adenomyosis by intrauterine pituitary grafting in mice.
  244. (2008). Strain-specific susceptibility to tamoxifen-induced adenomyosis in an animal model, 10th World Congress of Endometriosis,
  245. (1976). Stromal induction and specification of morphogenesis and cytodifferentiation of the epithelia of the mullerian ducts and urogenital sinus during development of the uterus and vagina in mice.
  246. (2000). Structural abnormalities of the uterine wall in women with endometriosis and infertility visualized by vaginal sonography and magnetic resonance imaging.
  247. (2004). Structural and functional roles of desmin in mouse skeletal muscle during passive deformation.
  248. (1994). Study of oestrogen and progesterone receptors in normal endometrium during the menstrual cycle by immunohistochemical analysis.
  249. (2008). Study of proliferation and apoptosis indices in uterine adenomyosis, 10th World Congress of Endometriosis,
  250. (1984). Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase.
  251. (1988). The current state of hysterosalpingography.
  252. (1999). The cyclic pattern of the immunocytochemical expression of oestrogen and progesterone receptors in human myometrial and endometrial layers: characterization of the endometrial-subendometrial unit.
  253. (1992). The distribution and possible function of gamma-interferon-immunoreactive cells in normal endometrium and myometrium.
  254. (1999). The distribution of endometrial leukocytes and their proliferation markers in trimegestone-treated postmenopausal women compared to the endometrium of the natural cycle: a dose-ranging study.
  255. (1996). The dynamics of rapid sperm transport through the female genital tract. Evidence from vaginal sonography of uterine peristalsis (VSUP) and hysterosalpingoscintigraphy (HSSG).
  256. (1968). The early response of immature rat myometrium to estrogenic stimulation.
  257. (1975). The effect of oestradiol on the DNA synthesis in neonatal mouse uterus and cervix.
  258. (2007). The effects of estradiol and tamoxifen therapy on myometrial differentiation and organisation during early uterine development: an animal model,
  259. (2009). The effects of tamoxifen and estradiol on myometrial differentiation and organisation during early uterine development in the CD-1 mouse. Reproduction
  260. (1972). The elusive adenomyosis of the uterus--revisited.
  261. (1962). The elusive adenomyosis of the uterus. Its historical past and its present state of recognition.
  262. (1981). The induction of adenomyosis in mice by intrauterine pituitary isografts.
  263. (2004). The need to decide if all estrogens are intrinsically similar.
  264. (1986). The ontogeny of the mouse estrogen receptor: the pelvic region.
  265. (1970). The organization of myosin and actin in vertebrate smooth muscle.
  266. (1998). The practical assessment of endometrial morphology and function.
  267. (1984). The prognostic significance of adenomyosis in endometrial carcinoma.
  268. (2006). The role of endometrial-myometrial interface in the aetiopathology of uterine adenomyosis, Reproductive Sciences Section seminar,
  269. (2002). The snail superfamily of zinc-finger transcription factors.
  270. (1998). The ultrastructure of fibromyomatous myometrium and its relationship to infertility. Hum Reprod Update,
  271. (2005). The use of cDNA microarray to identify differentially expressed labor-associated genes within the human myometrium during labor.
  272. (2006). The uterine junctional zone.
  273. (1985). The uterus: in vitro MR-anatomic correlation of normal and abnormal specimens.
  274. (1962). The variation in the structure of erythrocyte nuclei with fixation.
  275. (1993). Three-dimensional observation on sarcoplasmic reticulum and caveolae in myocardium of spontaneously hypertensive rats.
  276. (1995). Transvaginal pulsed and color Doppler sonography for the evaluation of adenomyosis.
  277. (1992). Transvaginal ultrasonography in the diagnosis of diffuse adenomyosis.
  278. (1992). Transvaginal ultrasonography in the differential diagnosis of adenomyoma versus leiomyoma.
  279. (1998). Transvaginal ultrasound in the diagnosis of diffuse adenomyosis.
  280. (1997). Treatment of adenomyosis-associated menorrhagia with a levonorgestrelreleasing intrauterine device.
  281. Ueber uterusdruesen-neubildung.
  282. (2001). Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology.
  283. (1990). Ultrastructure of smooth muscle tissue in the female reproductive tract: uterus and oviduct.
  284. (1989). Ultrastructure of the myometrium.
  285. (1997). Unique CD8+ T cell-rich lymphoid aggregates in human endometrium.
  286. Untersuchungen uber die entwicklung und morphologie der menschlichen uterusmuskulatur.
  287. (2008). Upregulation of PSCDBP, TLR2, TWIST1, FLJ35382, EDNRB, and RGS12 gene expression in human myometrium at labor.
  288. (1988). Use of immunocytochemistry of progesterone and oestrogen receptors for endometrial dating.
  289. (2003). Uterine adenomyosis in the infertility clinic.
  290. (2010). Uterine adenomyosis is associated with ultrastructural features of altered contractility in the inner myometrium. Fertil Steril
  291. (1998). Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization.
  292. (2004). Uterine extracellular matrix components are altered during defective decidualization in interleukin-11 receptor alpha deficient mice.
  293. Uterine hyperperistalsis and dysperistalsis as dysfunctions of the mechanism of rapid sperm transport in patients with endometriosis and infertility.
  294. (2007). Uterine innervation in adenomyosis.
  295. (1991). Uterine junctional zone: correlation between histologic findings and MR imaging.
  296. (1995). Uterine junctional zone: function and disease.
  297. (1989). Uterine junctional zone: MR study of water content and histologic examination of water content and relaxation properties.
  298. (1989). Uterine junctional zone: MR study of water content and relaxation properties.
  299. (2000). Uterine leukocytes and decidualization.
  300. (1986). Uterine MR imaging: effects of hormonal stimulation.
  301. (2002). Uterine peristaltic activity during the menstrual cycle: characterization, regulation, function and dysfunction.
  302. (2008). WikiPathways WikiPathways: pathway editing for the people. PLoS biology,
  303. (2004). Wnt5a is required for proper epithelial-mesenchymal interactions in the uterus.
  304. (2001). Xanthine oxidase in eutopic and ectopic endometrium in endometriosis and adenomyosis.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.